These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 190608

  • 1. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA, Ylikahri R, Huttunen JK.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [Abstract] [Full Text] [Related]

  • 2. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG, Rössner S, Walldius G, Carlson LA.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.
    Vessby B, Lithell H, Boberg J, Hellsing K, Werner I.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):32-7. PubMed ID: 798194
    [Abstract] [Full Text] [Related]

  • 4. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
    Sirtori CR, Franceschini G, Gianfranceschi G, Sirtori M, Montanari G, Tremoli E, Maderna P, Colli S, Zoppi F.
    J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
    [Abstract] [Full Text] [Related]

  • 5. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [Abstract] [Full Text] [Related]

  • 6. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG, Ekelund LG, Carlson LA.
    Acta Med Scand; 1975 Dec; 198(1-2):55-73. PubMed ID: 170796
    [Abstract] [Full Text] [Related]

  • 7. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K, Sasaki J, Arakawa K.
    Clin Ther; 1989 Dec; 11(3):331-40. PubMed ID: 2743372
    [Abstract] [Full Text] [Related]

  • 8. The effect of gemfibrozil on serum lipids in diabetic patients.
    Konttinen A, Kuisma I, Ralli R, Pohjola S, Ojala K.
    Ann Clin Res; 1979 Dec; 11(6):240-5. PubMed ID: 398183
    [Abstract] [Full Text] [Related]

  • 9. The evaluation of lipoprotein changes during gemfibrozil treatment.
    Janus ED, Costa D, Ononogbu IC, Lewis B.
    Proc R Soc Med; 1976 Dec; 69 Suppl 2(Suppl 2):76-7. PubMed ID: 1019156
    [Abstract] [Full Text] [Related]

  • 10. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Dec; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
    van Vlijmen BJ, Pearce NJ, Bergö M, Staels B, Yates JW, Gribble AD, Bond BC, Hofker MH, Havekes LM, Groot PH.
    Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA.
    Acta Med Scand; 1978 Apr; 204(3):211-8. PubMed ID: 211802
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER, Sutherland WH, Temple Wa.
    N Z Med J; 1980 Nov 12; 92(671):345-9. PubMed ID: 6935550
    [Abstract] [Full Text] [Related]

  • 16. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P, Weisweiler P, Neureuther G.
    Artery; 1979 Feb 12; 5(2):117-24. PubMed ID: 231950
    [Abstract] [Full Text] [Related]

  • 17. Effect of gemfibrozil on serum lipids in man.
    Fenderson RW, Deutsch S, Menachemi E, Chin B, Samuel P.
    Angiology; 1982 Sep 12; 33(9):581-93. PubMed ID: 6751166
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan 12; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 19. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J, Sauvanet JP, Chanu B, Bakir R, Goy-Loeper J, Saya C, Pinaroli F.
    Nouv Presse Med; 1980 Dec 22; 9(49):3747-51. PubMed ID: 7208341
    [Abstract] [Full Text] [Related]

  • 20. The preheparin and postheparin lipids of high density lipoprotein subfractions: relation to the serum insulin and postheparin plasma lipase activities in normal human.
    Skottová N, Vaverková H, Vecera R, Bartek J.
    Acta Univ Palacki Olomuc Fac Med; 1992 Dec 22; 134():69-74. PubMed ID: 1364970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.